CSF1R

There are 59 papers on CSF1R in aging research: 4 observational studies in people, 46 in animals, 6 reviews. The newest story, Nov 13, 2026: “Bile acid reduced bone loss in mice with ovaries removed”.

Gene

59 papers study it6 findings

HGNCMGINCBI GeneTaxon

5 new papers in 30 daysSee all 59 papers on CSF1R

At a glance

The findings reach mice, none yet in people. 5 independent labs in 4 countries; 9 trials, 3 with no results posted.

None of its findings points the other way.

Cells and mice: a single group. Worms or flies and humans: nothing yet.
  • 5 independent labs in 4 countries
  • 9 trials, 3 with no results posted
  • Funders: Bundesministerium für Forschung, Technologie und Raumfahrt and others
  • 1 of 5 findings with company ties
  • 9 of 9 trials sponsored by developers of drugs aimed at it
  • Humans4
  • Animals46
  • In silico3

Interventions

1

Bisabolangelone

downin mouse cells1

1 study
  1. Bisabolangelone inhibits CSF1R in mouse cells (binding shown by docking, molecular dynamics and CETSA; reversed by CSF1R overexpression).

    “Furthermore, Bisabolangelone inhibited osteoclast formation by binding to CSF1R, and overexpression of CSF1R reversed the inhibitory effects of Bisabolangelone on osteoclastogenesis.”

    Cellsbinding shown by docking, molecular dynamics and CETSA; reversed by CSF1R overexpression

    Bisabolangelone targets CSF1R to impede osteoclastogenesis and attenuate estrogen-deficiency bone loss

    Phytomedicine : international journal of phytotherapy and phytopharmacology

More on Bisabolangelone

Effects

4

White matter microstructure

downin mice1

1 study
  1. CSF1R protects against white matter microstructure in mice (shown by partial Csf1r loss in Csf1r+/- mice).

    “Aged females showed reduced fractional anisotropy and neurite density in the corpus callosum and left primary motor cortex”

    Animalsshown by partial Csf1r loss in Csf1r+/- micecorpus callosum and left primary motor cortexfemales

    CSF1R haploinsufficiency reveals subtle and selective age- and sex-dependent vulnerabilities in cognition and white matter without overt neurodegeneration

    Neurobiology of disease

Exogenous microglia replacement

upin reviews1

1 study
  1. CSF1R improves exogenous microglia replacement under selective small-molecule pressure.

    “engineering an inhibitor-resistant colony-stimulating factor 1 receptor (CSF1R) point mutation enables exogenously administered microglia to robustly outcompete and replace maladaptive, pro-inflammatory host microglia under selective small-molecule pressure.”

    Reviewunder selective small-molecule pressure

    Retinal Pigment Epithelium and Microglia Transplantation in Age-related Macular Degeneration

    American journal of ophthalmology

Activation-associated microglial states

is required forin mice1

1 study
  1. CSF1R is required for activation-associated microglial states in mice (activation-associated microglial states).

    “activation-associated microglial states are dependent on interferon and colony-stimulating factor 1 receptor signaling”

    Animalsactivation-associated microglial states

    A transcriptomic microglia taxonomy across mouse and human pathologies

    Nature immunology

Neuron loss

downin mice1

1 study
  1. CSF1R protects against neuron loss in Csf1rΔFIRE/ΔFIRE mice.

    “The thalamus is particularly vulnerable to neuropathological changes in the absence of microglia, with atrophy, neuron loss, vascular alterations, macroglial dysregulation, and severe tissue calcification.”

    Animalsin Csf1rΔFIRE/ΔFIRE micethalamus

    Microglia protect against age-associated brain pathologies

    Neuron

Upstream

1

Age

downin mice1

1 study
  1. Age decreases CSF1R in mice.

    “csf1ra/CSF1R expression in zebrafish AGM-derived microglia and murine adult microglia also undergo age-dependent decline”

    Animalsbrain

    Cell competition for neuron-derived trophic factor controls the turnover and lifespan of microglia

    Science advances

Funding

1 grant since 2026

National Institute on Aging$875K

Latest

Dec 2025: 4Jan 2026: 3Feb 2026: 1Mar 2026: 2Apr 2026: 1May 2026: 2Jun 2026: 1Jul 2026: 1Aug 2026: 1Sep 2026: 1Oct 2026: 3Nov 2026: 222 papers in 12 months
bioRxiv

Bile acid reduced bone loss in mice with ovaries removed

In a 45-day experiment, deoxycholic acid improved bone structure in mice whose ovaries had been removed to model bone loss after menopause.In a 45-day experiment, deoxycholic acid improved bone structure in mice whose ovaries had been removed to model bone loss after menopause.

Preprint: mouse studyBone loss
Alzheimer's Research & Therapy

Spinal-fluid protein linked to Alzheimer’s progression

Higher levels of one spinal-fluid protein were linked to greater dementia risk, with a hazard ratio of 1.325, a measure of relative risk.Higher levels of one spinal-fluid protein were linked to greater dementia risk, with a hazard ratio of 1.325, a measure of relative risk.

Cohort · 706 peopleMechanisms
Alzheimer's & Dementia

Reducing brain immune cells restores sleep in mice

Mice with amyloid plaques gained more than 2 hours of sleep per day over pretreatment levels, without a change in plaque burden.Mice with amyloid plaques gained more than 2 hours of sleep per day over pretreatment levels, without a change in plaque burden.

Mouse studyMechanisms

See all 59 papers on CSF1R